A reconciliation of the numerator and denominator of basic and diluted earnings per share is shown below (in thousands, except per share amounts):


	For the three months ended
	June 30,
	2026		2025
Basic earnings per share:


Net earnings	$	17,515	$	7,747

Basic weighted-average shares outstanding	60,506		65,448
Dilutive effect of common stock options and restricted stock units as computed under the treasury stock method	1,340		1,283
Diluted weighted-average shares outstanding	61,846		66,731

Basic earnings per share:


Basic earnings per share:	$	0.29	$	0.12

Diluted earnings per share:


Diluted earnings per share:	$	0.28	$	0.12

Anti-dilutive equity awards under stock-based award plans excluded from the determination of diluted earnings per share	654		1,595

Earnings per share totals may not sum due to rounding.

On February 12, 2026, the Company's board of directors approved an amendment to the existing common stock repurchase program, which was initially adopted in 2011. The amendment authorized an additional $200.0 million in share repurchases, increasing the total amount authorized for repurchase under the common stock repurchase program to $1.5 billion. In addition, it extended the common stock repurchase program duration through December 31, 2027.

During the three months ended June 30, 2026, the Company repurchased 0.6 million shares of its common stock for $17.6 million under the common stock repurchase program. Through June 30, 2026, the Company had repurchased a total of 49.2 million shares of its common stock for $1.3 billion under the program, leaving remaining capacity of $244.2 million. In accordance with the Merger Agreement, the Company has paused repurchases under its stock repurchase program through the completion of the Merger.

Accumulated foreign currency translation adjustments accounted for the $5.6 million accumulated other comprehensive income balance at both June 30, 2026 and March 31, 2026.